Alex is the Chief Financial Officer (CFO) of Epirium Bio. Prior to joining Epirium, Alex was founder, CEO and Portfolio Manager of Reneo Capital Management LP. A successful healthcare investor and executive, Alex brings more than 20 years of experience shaping and advising biopharmaceutical companies. Prior to forming Reneo, he served in roles including CFO of Sophiris Bio and Vice President of Finance of Amylin Pharmaceuticals. Previously, he served as a board member for Ignyta; and he ran Casdin Advisors LLC, providing strategic advice to life science companies, including Amylin. Before founding Casdin Advisors, Alex was CEO and Portfolio Manager of Cooper Hill Partners LLC, a healthcare investment fund, and before that, as Portfolio Manager of Pequot Capital Management’s healthcare fund. Earlier, Alex worked at the Dreyfus Corporation as a Senior Managing Analyst covering pharmaceuticals, biotechnology and medical devices. He also served as a Legislative Assistant to Congressman Robert J. Mrazek (D-NY) and then as Legislative Affairs Specialist for Patton Boggs LLP in Washington, D.C. He currently serves as on the Advisory Board of Luna DNA. He also is a board member, treasurer and executive committee member of the Conquer Cancer foundation of the American Society of Clinical Oncology, and a member of Brown University’s President’s Leadership Council. He also serves on the Advisory Board of the Hassenfeld Children’s Center for Pediatric Oncology and Blood Disorders at NYU Langone Medical Center. Alex holds an A.B. in Political Science from Brown University and an MBA, Beta Gamma Sigma, from Columbia Business School.